Autres langues Protara Therapeutics, Inc.

Actions

TARA

US74365U1079

Marché Fermé - Nasdaq Autres places de cotation 21:59:56 06/05/2024			Varia. 5j.	Varia. 1 janv.
2,91 ^USD	0,00%		-6,77%	+54,13%

02/05	Protara Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
05/04	Protara Therapeutics, Inc. annonce un alignement avec la FDA sur la voie de l'enregistrement pour le chlorure de choline IV chez les patients dépendant de la nutrition parentérale	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Protara Therapeutics: Q1 Earnings Snapshot	02/05
Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update	02/05
Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors	30/04
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing	05/04
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Resignation of Jathin Bandari as Chief Medical Officer, Effective April 11, 2024	18/03
Protara Therapeutics: Q4 Earnings Snapshot	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	13/03
Proteon Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
North American Morning Briefing : Stock Futures -2-	13/03
Top Premarket Gainers	12/03
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02
Top Premarket Decliners	12/02
Protara Therapeutics to Participate in Upcoming Investor Conferences	31/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Protara Therapeutics, Inc.

Actions

TARA

US74365U1079

Autres langues

Filtres